Characterization of factors regulating the activity of hepatocyte growth factor which is being developed for a medicine
正在开发用于药物的肝细胞生长因子活性调节因子的表征
基本信息
- 批准号:09480161
- 负责人:
- 金额:$ 8.51万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Hepatocyte growth factor (HGF) is a potent factor responsible for liver regeneration, and is being developed for a medicine of liver disease. The activity of HGF is regulated by extracellular and intracellular factors. In this study, we analyzed the function of these factors in regulating the activity of HGF and obtained the following results.(1) HGF activator (HGFA) was identified as a serine protease responsible for activation of HGF after liver injury. Analysis of HGFA after liver injury revealed that amount of HGFA mRNA increased, and HGFA was activated following liver injury.(2) Two types of HGFA inhibitors (HAIs) were identified as potent inhibitors of HGFA.cDNA cloning revealed that both HAIs are serine protease inhibitors with Kunitz domains. Introduction of mutations in the Kunitz domains markedly reduced the activity of HAIs, indicating that the domains are essential for the activity. Immunoblotting analysis demonstrated that HAIs are initially produced in transmembrane forms, and then secreted by the producing cells by proteolytic processing.(3) Hrs and its binding protein (Hbp) were identified as intracellular molecules regulating the activity of HGF.Functional characterization of Hrs/Hbp complexes revealed that the complexes are localized to early endosomes and play an important role in regulating the degradation of HGF and its receptor after internalization. Further, deubiquitinating enzyme UBPY was isolated as a binding partner of the SH3 domain of Hbp, suggesting that UBPY regulates the function of the Hrs/Hbp complexes.
肝细胞生长因子(HGF)是负责肝脏再生的有效因子,并且正在被开发用于肝病药物。 HGF 的活性受细胞外和细胞内因子的调节。本研究分析了这些因素在调节HGF活性中的作用,得到了以下结果:(1)HGF激活剂(HGFA)被鉴定为一种丝氨酸蛋白酶,负责肝损伤后HGF的激活。肝损伤后的HGFA分析显示,肝损伤后HGFA mRNA量增加,HGFA被激活。(2)两种HGFA抑制剂(HAI)被鉴定为HGFA的有效抑制剂。cDNA克隆显示这两种HAI都是丝氨酸蛋白酶具有 Kunitz 结构域的抑制剂。 Kunitz 结构域中引入的突变显着降低了 HAI 的活性,表明这些结构域对于该活性至关重要。免疫印迹分析表明HAI最初以跨膜形式产生,然后由产生细胞通过蛋白水解加工分泌。(3)Hrs及其结合蛋白(Hbp)被鉴定为调节HGF活性的细胞内分子。Hrs/的功能表征Hbp复合物揭示该复合物定位于早期内体,在内化后在内体化过程中在内体调节HGF及其受体的降解中发挥重要作用。此外,分离出去泛素化酶 UBPY 作为 Hbp SH3 结构域的结合伴侣,表明 UBPY 调节 Hrs/Hbp 复合物的功能。
项目成果
期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A.Okajima: "Induction of hepatocyte growth factor activator mRNA in the liver following tissue injury and acute inflammation." Hepatology. 25. 97-102 (1997)
A.Okajima:“组织损伤和急性炎症后肝脏中肝细胞生长因子激活剂 mRNA 的诱导。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
L.Lu: "Human Hrs, a tyrosine kinase substrate in growth factor-stimulated cells : cDNA cloning and mapping of the gene to chromosome 17." Gene. 213. 125-132 (1998)
L.Lu:“人类 Hrs,生长因子刺激细胞中的一种酪氨酸激酶底物:cDNA 克隆以及该基因到 17 号染色体的定位。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Matsubara: "Hepatocyte growth factor activator ; a possible regulator of morphogenesis during the fetal development of rat gastrointestinal tract." Biochem.Biophys.Res.Commun.253. 477-484 (1998)
Y.Matsubara:“肝细胞生长因子激活剂;大鼠胃肠道胎儿发育过程中形态发生的可能调节剂。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Kawaguchi et al.: "Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor." J.Biol.Chem.272. 27558-27564 (1997)
T.Kawaguchi 等人:“2 型肝细胞生长因子激活剂抑制剂(一种 Kunitz 型丝氨酸蛋白酶抑制剂)的纯化和克隆。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Kaibori: "Stimulation of liver regeneration and function after partial hepatectomy in cirrhotic rats by continuous infusion of recombinant human hepatocyte growth factor." J.Hepatology. 27. 381-390 (1997)
M.Kaibori:“通过连续输注重组人肝细胞生长因子,刺激肝硬化大鼠部分肝切除术后的肝脏再生和功能。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KITAMURA Naomi其他文献
KITAMURA Naomi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KITAMURA Naomi', 18)}}的其他基金
Regulation of the endosomal sorting and intracellular signaling ofgrowth factor receptors
生长因子受体内体分选和细胞内信号传导的调节
- 批准号:
19370050 - 财政年份:2007
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanism of regulation of growth factor receptor sorting at endosomes
内体生长因子受体分选调节的分子机制
- 批准号:
17370045 - 财政年份:2005
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanism of endosomal sorting of growth factors and receptors
生长因子和受体内体分选的分子机制
- 批准号:
15370053 - 财政年份:2003
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterization of the regulatory mechanism of endocytosis of growth factors and receptors
生长因子和受体内吞调节机制的表征
- 批准号:
13480235 - 财政年份:2001
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterization of hepatocyte growth factor activator inhibitors which are being developed for a medicine
正在开发的药物肝细胞生长因子激活剂抑制剂的表征
- 批准号:
13557012 - 财政年份:2001
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional characterization of novel regulators of vesicular transport in endocytosis and exocytosis
胞吞作用和胞吐作用中囊泡运输的新型调节剂的功能表征
- 批准号:
11480206 - 财政年份:1999
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Characterization of factors regulating the activity of hepatocyte growth factor which is being developed for a medicine
正在开发用于药物的肝细胞生长因子活性调节因子的表征
- 批准号:
10557017 - 财政年份:1998
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional characterization of a novel tyrosine phosphorylated protein in signal transduction of hepatocyte growth factor
新型酪氨酸磷酸化蛋白在肝细胞生长因子信号转导中的功能表征
- 批准号:
07458164 - 财政年份:1995
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Structural and functional characterization of a novel serine protease responsible for activation of hepatocyte growth factor
负责肝细胞生长因子激活的新型丝氨酸蛋白酶的结构和功能表征
- 批准号:
05454625 - 财政年份:1993
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Functional analysis of domain structures of human hepatocyte growth factor
人肝细胞生长因子结构域的功能分析
- 批准号:
02454540 - 财政年份:1990
- 资助金额:
$ 8.51万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
枯否细胞SYK磷酸化激活STING信号通路导致脓毒症肝损伤
- 批准号:82372153
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高产乙醇肺炎克雷伯菌通过IL-17和自噬途径引发肝损伤机制的研究
- 批准号:82302540
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
线粒体能量失衡及糖代谢重编程在量子点诱发肝免疫性损伤中的毒作用分子机制
- 批准号:82373618
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
鼠李糖乳杆菌通过ILA/PXR/CYP3A4轴缓解雷公藤肝损伤的机制研究
- 批准号:82300680
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
产酸拟杆菌通过代谢产物N-乙酰血清素激活IDO1-AhR信号介导Treg-巨噬细胞轴减轻脓毒症肝损伤的作用及机制
- 批准号:82330067
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
相似海外基金
Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
- 批准号:
10751760 - 财政年份:2024
- 资助金额:
$ 8.51万 - 项目类别:
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
- 批准号:
10354185 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Role of STING in Cholestatic Liver Injury
STING 在胆汁淤积性肝损伤中的作用
- 批准号:
10637131 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Senescent hepatocytes mediate reprogramming of immune cells in acute liver failure
衰老肝细胞介导急性肝衰竭中免疫细胞的重编程
- 批准号:
10679938 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别: